Recent advances in adjuvant systemic therapy for early-stage breast cancer

被引：4

作者：

Bedard, P. L. ^{[1
]}

Cardoso, F. ^{[1
]}

机构：

[1] Inst Jules Bordet, B-1000 Brussels, Belgium

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

10.1093/annonc/mdn325

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：122 / 127

页数：6

共 57 条

[1]

Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0

[2]

[Anonymous], BREAST CANC RES T S1

[3]

BONANNI B, 2007, SAN ANT BREAST CANC

[4] Benefit of taxanes as adjuvant chemotherapy for early breast cancer - Pooled analysis of 15,500 patients [J].

Bria, Emilio ;

Nistico, Cecilia ;

Cuppone, Federica ;

Carlini, Paolo ;

Ciccarese, Mariangela ;

Milella, Michele ;

Natoli, Guido ;

Terzoli, Edmondo ;

Cognetti, Francesco ;

Giannarelli, Diana .

CANCER, 2006, 106 (11) :2337-2344

[5]

BURNELL M, 2006, SAN ANT BREAST CANC

[6]

BURNELL MJ, 2007, P AN M AM SOC CLIN, V25, P550

[7] Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy [J].

Cui, XJ ;

Schiff, R ;

Arpino, G ;

Osborne, CK ;

Lee, AV .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7721-7735

[8] Taxane-based combinations as adjuvant chemotherapy of early breast cancer: A meta-analysis of randomized trials [J].

De Laurentiis, Michele ;

Cancello, Giuseppe ;

D'Agostino, Diego ;

Giuliano, Mario ;

Giordano, Antonio ;

Montagna, Emilia ;

Lauria, Rossella ;

Forestieri, Valeria ;

Esposito, Angela ;

Silvestro, Lucrezia ;

Pennacchio, Roberta ;

Criscitiello, Carmen ;

Montanino, Agnese ;

Limite, Gennaro ;

Bianco, Angelo Raffaele ;

De Placido, Sabino .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) :44-53

[9] Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: An hypothesis-generating study [J].

Dowsett, M ;

Cuzick, J ;

Wale, C ;

Howell, T ;

Houghton, J ;

Baum, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7512-7517

[10] Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the arimidex, tamoxifen, alone or in combination trial [J].

Dowsett, Mitch ;

Allred, Craig ;

Knox, Jill ;

Quinn, Emma ;

Salter, Janine ;

Wale, Chris ;

Cuzick, Jack ;

Houghton, Joan ;

Williams, Norman ;

Mallon, Elizabeth ;

Bishop, Hugh ;

Ellis, Ian ;

Larsimont, Denis ;

Sasano, Hironobu ;

Carder, Pauline ;

Cussac, Antonio Llombart ;

Knox, Fiona ;

Speirs, Valerie ;

Forbes, John ;

Buzdar, Aman .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) :1059-1065

← 1 2 3 4 5 6 →